Effects of intradermal injection of atrial natriuretic peptide

A. M. Sharara, M. A. Higham, A. Spanevello, P. W. Ind

Research output: Contribution to journalArticlepeer-review


Atrial natriuretic peptide (ANP) causes mast cell degranulation in rats in vivo and vitro but is bronchodilator in humans. The aim of this study was to investigate the wheal and flare dose-response to intradermal injection of α-human ANP in normal humans. Eight normal subjects received five 30 μl injections containing 1, 10, 39, 78, 117 pmol ANP and one each of normal saline, histamine 675 pmol and substance P 30 pmol. Maximum ANP flare response was greater but not significantly than that to saline at 1.55 ± 0.6 (mean ± s.e. mean) compared with 0.42 ± 0.17 cm 2, but much less than to histamine 9.86 ± 0.97 or to substance P 12.5 ± 1.2. Maximum ANP wheal response was significantly greater than that to saline at 0.38 ± 0.08 compared with 0.18 ± 0.05 cm 2 (difference between means 0.20, 95% CI 0.05, 0.35), but much less than to histamine 0.75 ± 0.06 or to substance P 1.05 ± 0.08 cm 2. No dose-response to ANP was demonstrated, though responses to the highest dose differed significantly from those to the lowest dose studied. We conclude that human cutaneous responses to ANP differ from those of animals and that the skin is less responsive than other tissues in humans.

Original languageEnglish
Pages (from-to)283-285
Number of pages3
JournalBritish Journal of Clinical Pharmacology
Issue number3
Publication statusPublished - 1995


  • Atrial natriuretic peptide
  • Flare
  • Human skin
  • Wheal

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Effects of intradermal injection of atrial natriuretic peptide'. Together they form a unique fingerprint.

Cite this